Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Trey Thoelcke | Oct 17, 2012 at 9:02 AM EDT

Abbott Labs Q3 Profit Surges, but Revenues Slip

Abbott Laboratories (NYSE: ABT) said that third-quarter earnings surged, despite a slip in revenue, due to a double-digit decline in…

Jon C. Ogg | Oct 16, 2012 at 3:59 PM EDT

Options Evaluation After FDA Panel Backing For NPS Pharma

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) may not yet have formal approval for its short bowel syndrome drug called Gattex, but…

Trey Thoelcke | Oct 16, 2012 at 8:07 AM EDT

Johnson & Johnson Tops Earnings Expectations

Johnson & Johnson (NYSE: JNJ) reported fiscal third-quarter results before markets opened this morning. The health care giant posted earnings…

Paul Ausick | Oct 16, 2012 at 7:33 AM EDT

UnitedHealth Rises on Fewer Claims

UnitedHealth Group Inc. (NYSE: UNH) reported fiscal third-quarter results before markets opened this morning. The health insurer posted diluted earnings…

Trey Thoelcke | Oct 11, 2012 at 8:25 AM EDT

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September…

Jon C. Ogg | Oct 10, 2012 at 2:40 PM EDT

Amarin Becomes A January 2013 Story on FDA Uncertainty

Amarin Corporation plc (NASDAQ: AMRN) is not exactly having a good day considering that its fish oil based drug for lowering…

Jon C. Ogg | Oct 9, 2012 at 9:40 AM EDT

Analysts in Defense of Edwards Lifesciences

Edwards Lifesciences Corp. (NYSE: EW) is the big disappointment of the day on Tuesday after the company lowered its TAVI sales…

Trey Thoelcke | Oct 9, 2012 at 6:54 AM EDT

Coca-Cola, PepsiCo Join Calories Count Initiative

The American Beverage Association’s President Susan Neely said members of her group have agreed to what they call the Calories…

Jon C. Ogg | Oct 8, 2012 at 1:30 PM EDT

Lilly Adds $1 Billion in Market Value from Alzheimer’s Study Data

Eli Lilly & Co. (NYSE: LLY) is confirming prior news showing that late-stage trial data analysis showed the the primary endpoints…

Paul Ausick | Oct 8, 2012 at 8:40 AM EDT

UnitedHealth Acquires Brazilian Insurer

U.S. health insurer UnitedHealth Group Inc. (NYSE: UNH) today announced that it is acquiring Brazilian health insurer Amil Participacoes S.A.…

Paul Ausick | Oct 8, 2012 at 8:17 AM EDT

Bidding Starts for Allscripts (MDRX, BX, CG)

Electronic health-records provider Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) said late last month that it would explore a sale of…

Paul Ausick | Oct 5, 2012 at 8:13 AM EDT

Cell Therapeutics Collapses on Secondary Offering

Biopharmaceutical firm Cell Therapeutics Inc. (NASDAQ: CTIC) announced a secondary offering this morning of 60,000 shares of its Series 17…

Jon C. Ogg | Oct 3, 2012 at 12:53 PM EDT

How Sarepta Got On The Map

Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a company which many biohealth and biotech investors have likely never heard of. At least…

Douglas A. McIntyre | Sep 27, 2012 at 6:32 AM EDT

Companies That Will Not Be Hurt by the Fiscal Cliff

The fiscal cliff has been described as a potential disaster for the finances of individuals and corporations alike. If Congress…

Trey Thoelcke | Sep 26, 2012 at 8:53 AM EDT

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short…

1 … 312 313 314 315 316 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Abbott Labs Q3 Profit Surges, but Revenues Slip

Options Evaluation After FDA Panel Backing For NPS Pharma

Johnson & Johnson Tops Earnings Expectations

UnitedHealth Rises on Fewer Claims

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Amarin Becomes A January 2013 Story on FDA Uncertainty

Analysts in Defense of Edwards Lifesciences

Coca-Cola, PepsiCo Join Calories Count Initiative

Lilly Adds $1 Billion in Market Value from Alzheimer’s Study Data

UnitedHealth Acquires Brazilian Insurer

Bidding Starts for Allscripts (MDRX, BX, CG)

Cell Therapeutics Collapses on Secondary Offering

How Sarepta Got On The Map

Companies That Will Not Be Hurt by the Fiscal Cliff

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Health and Healthcare Articles

All Health and Healthcare Articles

Abbott Labs Q3 Profit Surges, but Revenues Slip

Options Evaluation After FDA Panel Backing For NPS Pharma

Johnson & Johnson Tops Earnings Expectations

UnitedHealth Rises on Fewer Claims

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Amarin Becomes A January 2013 Story on FDA Uncertainty

Analysts in Defense of Edwards Lifesciences

Coca-Cola, PepsiCo Join Calories Count Initiative

Lilly Adds $1 Billion in Market Value from Alzheimer’s Study Data

UnitedHealth Acquires Brazilian Insurer

Bidding Starts for Allscripts (MDRX, BX, CG)

Cell Therapeutics Collapses on Secondary Offering

How Sarepta Got On The Map

Companies That Will Not Be Hurt by the Fiscal Cliff

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

ISPY’s 0.56% Fee Hides a $38,000 Decade-Long Performance Gap Against SPY

Featured Reads

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

The Portfolio Blueprint for Building $50,000 a Month in Dividend Income